by Oscar Jofre | Feb 17, 2022 | Capital Markets, Capital Raising
Manny Villafaña has a long track record of innovation in the medtech space, delivering solutions to improve cardiac care and surgical procedures. In his latest venture, Manny is creating a product that will change the way cardiac bypass surgeries are performed,...
by Oscar Jofre | Feb 16, 2022 | KoreConX
When companies begin the capital raising journey, it is no longer about going public or simply getting a company’s product in front of venture capitalists. To be successful in our current capital raising landscape with Regulations A+ and CF, organizations must...
by Oscar Jofre | Feb 14, 2022 | KoreConX
Whether you’ve raised capital in the past or are preparing for your first round, being properly prepared will help your company secure the funding it needs. Proper preparation will make investors confident that you are ready for their investments and have a foundation...
by Oscar Jofre | Feb 11, 2022 | KoreConX
Rule 12(g) is a crucial rule that affects all issuers, but many issuers don’t start with it in mind. The rule began with the 1934 Exchange Act, and it states the threshold at when an issuer must register securities with the SEC. Read further to learn what rule 12(g)...
by Oscar Jofre | Feb 8, 2022 | Capital Markets, Capital Raising, KoreConX, News Releases
‘Father of the JOBS Act,’ Mr. Weild will join KoreConX to address a keynote on how Medtech is the new frontier to a successful capital raising NEW YORK, February 8, 2022 – KoreConX and its partner, Life Science Intelligence, are bringing together top...
